Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus

OBJECTIVE: To evaluate the long-term outcomes after treatment of cervical intraepithelial neoplasia (CIN) in women infected with the human immunodeficiency virus (HIV). METHODS: Human immunodeficiency virus-infected and HIV-negative women treated for CIN by ablation or excision were followed-up prospectively by cytology and colposcopy for periods of up to 73 months. RESULTS: Among 127 HIV-infected CIN patients, 62% developed recurrent CIN by 36 months after treatment, compared with 18% of the 193 HIV-negative CIN patients. Recurrence rates reached 87% in 41 HIV-infected women with CD4 counts less than 200 cells/mm3. Progression to higher-grade neoplasia, including one invasive cancer, occurred by 36 months in 25% of HIV-infected and 2% of HIV-negative women. After adjusting for age, CIN severity, and treatment type, predictors of recurrence included HIV infection (rate ratio 4.4), and, in HIV-positive women, low CD4 count (rate ratio 2.2). In patients treated by excision, predictors of recurrence included HIV infection (rate ratio 2.0) and residual CIN after treatment (rate ratio 2.7). After a second treatment,a second CIN recurrence developed in 14 of 33 HIV-infected and in one of 17 HIV-negative women. After a third treatment, three of six HIV-infected women developed a third recurrence. With long-term follow-up, 45% of treated HIV-infected CIN patients had chronic condylomatous changes in the cervix compared with 5% of HIV-negative women. CONCLUSION: In HIV-infected women, CIN may recur despite multiple treatments, and chronic condylomatous changes are common. Innovative therapies for controlling CIN in HIV-infected women are needed.

This article has been cited by other articles:

				B. Kelly, J. Morrison, and P. Hurley Recent developments in HIV and women's health Obstet Gynaecol (Lond), January 1, 2008; 10(1): 42 - 48. [Abstract] [Full Text] [PDF]

				K. M. E. Gallagher and S. Man Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women J. Gen. Virol., May 1, 2007; 88(5): 1470 - 1478. [Abstract] [Full Text] [PDF]

				L S. Massad, C. T. Evans, H. Minkoff, D H. Watts, H. D. Strickler, T. Darragh, A. Levine, K. Anastos, M. Moxley, and D. J. Passaro Natural History of Grade 1 Cervical Intraepithelial Neoplasia in Women With Human Immunodeficiency Virus Obstet. Gynecol., November 1, 2004; 104(5): 1077 - 1085. [Abstract] [Full Text] [PDF]

				A. Kobayashi, R. M. Greenblatt, K. Anastos, H. Minkoff, L. S. Massad, M. Young, A. M. Levine, T. M. Darragh, V. Weinberg, and K. K. Smith-McCune Functional Attributes of Mucosal Immunity in Cervical Intraepithelial Neoplasia and Effects of HIV Infection Cancer Res., September 15, 2004; 64(18): 6766 - 6774. [Abstract] [Full Text] [PDF]

				L. F. Xi and N. B. Kiviat Cervical Neoplasia and Highly Active Antiretroviral Therapy J Natl Cancer Inst, July 21, 2004; 96(14): 1051 - 1053. [Full Text] [PDF]

				G. Taylor, T. Wolff, N. Khanna, P. Furth, and P. Langenberg Genital Dysplasia in Women Infected with Human Immunodeficiency Virus J Am Board Fam Med, March 1, 2004; 17(2): 108 - 113. [Abstract] [Full Text] [PDF]

				F. Walker, S. Kermorgant, E. Darai, P. Madelenat, A. C. Cremieux, D. Henin, and T. Lehy Hepatocyte Growth Factor and c-Met in Cervical Intraepithelial Neoplasia: Overexpression of Proteins Associated with Oncogenic Human Papillomavirus and Human Immunodeficiency Virus Clin. Cancer Res., January 1, 2003; 9(1): 273 - 284. [Abstract] [Full Text] [PDF]

				W. R. Robinson, J. Andersen, T. M. Darragh, M. A. Kendall, R. Clark, and M. Maiman Isotretinoin for Low-Grade Cervical Dysplasia in Human Immunodeficiency Virus-Infected Women Obstet. Gynecol., May 1, 2002; 99(5): 777 - 784. [Abstract] [Full Text] [PDF]

				B Clarke and R Chetty Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer Mol. Pathol., February 1, 2002; 55(1): 19 - 24. [Abstract] [Full Text] [PDF]

				J. R. GAGE, A. K. SANDHU, M. NIHIRA, M. D. G. BONECINI-ALMEIDA, P. CRISTOFORONI, T. KISHIMOTO, F. J. MONTZ, and O. MARTINEZ-MAZA Effects of Human Papillomavirus-Associated Cells on Human Immunodeficiency Virus Gene Expression Obstet. Gynecol., December 1, 2000; 96(6): 879 - 885. [Abstract] [Full Text] [PDF]

				M. Frisch, R. J. Biggar, and J. J. Goedert Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome J Natl Cancer Inst, September 20, 2000; 92(18): 1500 - 1510. [Abstract] [Full Text] [PDF]

				H A Cubie, A L Seagar, G J Beattie, S Monaghan, and A R W Williams A longitudinal study of HPV detection and cervical pathology in HIV infected women Sex Transm Inf, August 1, 2000; 76(4): 257 - 261. [Abstract] [Full Text] [PDF]

				M. MAIMAN, D. H. WATTS, J. ANDERSEN, P. CLAX, M. MERINO, and M. A. KENDALL Vaginal 5-Fluorouracil for High-Grade Cervical Dysplasia in Human Immunodeficiency Virus Infection: A Randomized Trial Obstet. Gynecol., December 1, 1999; 94(6): 954 - 961. [Abstract] [Full Text] [PDF]

				J. Savard, S. M. Miller, M. Mills, A. O'Leary, H. Harding, S. D. Douglas, C. E. Mangan, R. Belch, and A. Winokur Association Between Subjective Sleep Quality and Depression on Immunocompetence in Low-Income Women at Risk for Cervical Cancer Psychosom Med, July 1, 1999; 61(4): 496 - 507. [Abstract] [Full Text] [PDF]

				J. M. Palefsky, H. Minkoff, L. A. Kalish, A. Levine, H. S. Sacks, P. Garcia, M. Young, S. Melnick, P. Miotti, and R. Burk Cervicovaginal Human Papillomavirus Infection in Human Immunodeficiency Virus-1 (HIV)-Positive and High-Risk HIV-Negative Women J Natl Cancer Inst, February 3, 1999; 91(3): 226 - 236. [Abstract] [Full Text] [PDF]

				S. J. Goldie, M. C. Weinstein, K. M. Kuntz, and K. A. Freedberg The Costs, Clinical Benefits, and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women Ann Intern Med, January 19, 1999; 130(2): 97 - 107. [Abstract] [Full Text] [PDF]

				M. Maiman Management of Cervical Neoplasia in Human Immunodeficiency Virus-Infected Women J Natl Cancer Inst Monographs, April 1, 1998; 1998(23): 43 - 49. [Abstract] [Full Text]

				CIN RECURRENCE IN HIV-POSITIVE WOMEN Journal Watch (General), May 14, 1996; 1996(514): 5 - 5. [Full Text]